BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8428339)

  • 1. Oncogenes in prostate cancer. An update.
    Peehl DM
    Cancer; 1993 Feb; 71(3 Suppl):1159-64. PubMed ID: 8428339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
    Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth factors and oncogenes in prostate cancer.
    Thompson TC
    Cancer Cells; 1990 Nov; 2(11):345-54. PubMed ID: 2282250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated Ki-ras oncogene in human prostatic adenocarcinoma.
    Peehl DM; Wehner N; Stamey TA
    Prostate; 1987; 10(4):281-9. PubMed ID: 3601807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ha-ras and v-raf oncogenes, but not int-2 and c-myc, interfere with the lactogenic hormone dependent activation of the mammary gland specific transcription factor.
    Happ B; Hynes NE; Groner B
    Cell Growth Differ; 1993 Jan; 4(1):9-15. PubMed ID: 8424907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated transforming growth factor-beta 1 and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: evidence for a paracrine role during progression.
    Merz VW; Miller GJ; Krebs T; Timme TL; Kadmon D; Park SH; Egawa S; Scardino PT; Thompson TC
    Mol Endocrinol; 1991 Apr; 5(4):503-13. PubMed ID: 1922083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental oncogene induced prostate cancer.
    Thompson TC; Kadmon D; Timme TL; Merz VW; Egawa S; Krebs T; Scardino PT; Park SH
    Cancer Surv; 1991; 11():55-71. PubMed ID: 1726789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between bivariate expression of key oncogenes and metabolic phenotypes of patients with prostate cancer.
    Khodayari Moez E; Pyne S; Dinu I
    Comput Biol Med; 2018 Dec; 103():55-63. PubMed ID: 30340213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
    Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
    Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model to study c-myc and v-H-ras induced prostate cancer progression in the Copenhagen rat.
    Lehr JE; Pienta KJ; Yamazaki K; Pilat MJ
    Cell Mol Biol (Noisy-le-grand); 1998 Sep; 44(6):949-59. PubMed ID: 9763199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.
    Amundadottir LT; Leder P
    Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent advances in gene change of pancreatic cancer].
    Wang YY; Cui QC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):79-82. PubMed ID: 15052782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenes and growth factors in renal cell carcinoma.
    Peter S
    Urol Int; 1991; 47(4):199-202. PubMed ID: 1781103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Human papillomaviruses and cellular oncogenes (c-myc, c-Ha-ras) in cutaneous and mucosal lesions in transplantation recipients].
    PĂ©lisson I; Soler C; Chignol MC; Euvrard S; Chardonnet Y
    Bull Cancer; 1992; 79(5):471-82. PubMed ID: 1330099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Searching for the gatekeeper oncogene of prostate cancer.
    Gelmann EP
    Crit Rev Oncol Hematol; 2003 Jun; 46 Suppl():S11-20. PubMed ID: 12850523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel oncogene-induced metastatic prostate cancer cell lines define human prostate cancer progression signatures.
    Ju X; Ertel A; Casimiro MC; Yu Z; Meng H; McCue PA; Walters R; Fortina P; Lisanti MP; Pestell RG
    Cancer Res; 2013 Jan; 73(2):978-89. PubMed ID: 23204233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic predisposition and mesenchymal-epithelial interactions in ras+myc-induced carcinogenesis in reconstituted mouse prostate.
    Thompson TC; Timme TL; Kadmon D; Park SH; Egawa S; Yoshida K
    Mol Carcinog; 1993; 7(3):165-79. PubMed ID: 8489712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of growth factor, proto-oncogene and carcinoembryonic antigen gene expression in human colorectal carcinoma cell lines.
    La Rocca RV; Park JG; Danesi R; Del Tacca M; Steinberg SM; Gazdar AF
    Oncology; 1992; 49(3):209-14. PubMed ID: 1495747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic research in prostate cancer: molecular biology.
    Effert PJ; Strohmeyer TG
    Acta Urol Belg; 1994 Apr; 62(1):15-21. PubMed ID: 8197925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA ploidy and clonal selection in ras + myc-induced mouse prostate cancer.
    Greene DR; Taylor SR; Aihara M; Yoshida K; Egawa S; Park SH; Timme TL; Yang G; Scardino PT; Thompson TC
    Int J Cancer; 1995 Jan; 60(3):395-9. PubMed ID: 7829250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.